Abstract
Anorexia and bulimia nervosa (DSM-III-R, 1987) are disorders of unknown etiology which are characterized by alterations of appetitive behavior and distortions of body image. Eating disorder patients have dysphoric mood (Hudson et al., 1983a) and various forms of hypothalamic-pituitary dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham SF, Beumont PJV, Cobbin DM: Catecholamine metabolism and body weight in anorexia nervosa. Brit J Psychiatry 1981; 138: 244–247.
Ananth J, Pecknold JC, Van der Steen N, Engelsmann F: Double-blind compara-tive study of climopramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol Biol Psychiatry 1981; 5: 257–262.
Asbert M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193–1197.
Beary MD, Lacey JH, Merry J: Alcoholism and eating disorders in women of fertile age. Brit J Addiction 1986; 81: 685–689.
Beaumont PJV, George GCW, Smart DE: “Dieters” and “vomiters” in anorexia nervosa. Psychol Med 1976; 6: 617–622.
Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ: Urinary MHPG in anorexia nervosa patients with and without a concomitant major depressive disorder. J Psych Res 1984; 18: 149–160.
Biederman J, Herzog DB, Rivinus TM, et al: Amitryptyline in the treatment of anorexia nervosa: a double-blind study, placebo-controlled study. J Clin Psychopharmacol 1985a; 5: 10–16.
Biederman J, Rivinus T, Kemper K, Hamilton D, MacFadyen J, Harmatz, J: Depressive disorders in relatives of anorexia nervosa patients with and without a current episode of nonbipolar major depression. Am J Psychiatry 1985b; 142: 1495–1496.
Blouin AG, Glouin JF, Perez EL, Bushnik T, Zuro C, Mulder E: Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988; 8: 261–269.
Blundell JE: Serotonin and appetite. Neuropharmacology 1984; 23: 1537–1551.
Brewerton TD, Brandt HA, Lesern MD, Murphy DL, Jimerson DC: Serotonin in eating disorders. In: Coccaro EF, Murphy DL (Eds.), Serotonin in Major Psychiatric Disorders. Washington DC: American Psychiatric Press, 1990.
Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF: Aggression in human correlates with cerebrospinal fluid amine metabolites. Psych Res 1979; 1: 131–139.
Buckholtz N, George DT, Davies AO, Jimerson DC, Potter WZ: Lymphocyte beta-adrenergic receptor modification in bulimia. Arch Gen Psychiat 1988; 45: 479–482.
Bulik CM: Drug and alcohol abuse by bulimic women and their families. Am J Psychiatry 1987; 144: 1604–1606.
Cantwell DP, Sturzenburger S, Burroughs J, Salkin B, Green JK: Anorexia ner-vosa. An affective disorder? Arch Gen Psychiatry 1977; 3: 1087–1093.
Casper RC: Personality features of women with good outcome from restricting anorexia nervosa. Psychosomatic Med 1990; 52: 156–170.
Casper RC, Eckert ED, Halmi KA, Goldberg SC, Davis JM: Bulimia: Its incidence and clinical importance in patients with anorexia nervosa. Arch Gen Psychiatry 1980; 37: 1030–1035.
Charney DS, Woods SW, Goodman WK, Heninger GR: Serotonin function in anxiety. Psychopharmacology 1987; 92: 14–24.
Chiodo J, Latimer PR: Vomiting as a learned weight-control technique in bulimia. J Behav Ther Exp Psychiatry 1983; 14: 131.
Cloninger CR: Neurogenic adaptive mechanism in alcoholism. Science 1987; 235: 410–416.
Crisp AH, Lacey JH, Crutchfield M: Clomipramine and “drive” in people with anorexia nervosa. Brit J Psychiatry 1987; 50: 355–358.
Diagnostic and Statistical Manual of Mental Disorders,Washington DC: American Psychiatric Association, Third Edition, 1987.
Eckert ED, Goldberg SC, Halmi KA, Cooper RC, Davis JM: Depression in anorexia nervosa. Psychol Med 1982; 12: 115–122.
Esler M: Assessment of sympathetic nervous function in humans for noradrenaline plasma kinetics. Clin Sci 1982; 52: 247.
Freeman, CPL, Hampson M: Fluoxetine as a treatment for bulimia nervosa. Int J Obes 1987; 11 (Suppl 3): 171–177.
Freeman CP, Morris JE, Chesire KE et al: A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Third International Conference on Eating Disorders. New York, NY Abstract, 1988.
Garfinkel PE, Moldofsky H, Garner DM: The heterogeneity of anorexia nervosa. Arch Gen Psychiatry 1980; 37: 1036–1040.
Garner DM, Garfinkel PE, O’Shaughnessy M: The validity of the distinction between bulimia with and without anorexia nervosa. Am J Psychiatry 1985; 142: 581–587.
Garner DM, Fairburn C, Davis R: Cognitive-behavioral treatment of bulimia nervosa: A critical appraisal. Psychiatry Res 1990; 33: 1–10.
Gerner RH, Gwirtsman HE: Neurochemical abnormalities in anorexia nervosa: Similarities to affective disorders. Biol Psychiatry 1981; 16: 991–995.
Gerner RH, Cohen DJ, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Shaywitz BA, Hare TA: CSF neurochemistry of women with anorexia nervosa and normal women. Am J Psychiatry 1984; 141: 1441–1444.
Gershon ES, Schreiber JL, Hamovit JR, Dibble ED, Kaye WH, Nurnberger J, Anderson A, Ebert MH: Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiatry 1984; 141: 1419–1422.
Goldbloom DS, Hicks L, Garfinkel PE: Platelet serotonin uptake in bulimia nervosa. Biol Psychiatry 1990; 28: 644–647.
Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS: Efficacy of fluvoxamine in obsessive compulsive disorders. Arch Gen Psychiatry 1989; 20: 1174–1188.
Goodwin GM, Fairburn CG, Cowen PJ: The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers: Important implications for neuroendocrine investigations in depression. Arch Gen Psychiatry 1988; 44: 952–957.
Gross HA, Lake CR, Ebert MH, Ziegler MG, Kopin IJ: Catecholamine metabo-lism in primary anorexia nervosa. J Clin Endocrin Metab 1979; 49: 805–809.
Gross AH, Ebert MH, Faden VB: A double-blind controlled trial of lithium car-bonate in primary anorexia nervosa. J Clin Psychopharmacol 1981; 1: 376–381. Gwirtsman HE, Roy-Byrne P, Yager J, Gerner RH: Neuroendocrine abnormalities in bulimia. Am J Psychiatry 1983; 140: 559–563.
Gwirtsman HE, Kaye WH, Obarzanek E, George DT, Jimerson DT, Ebert MH: Decreased caloric intake in normal-weight patients with bulimia: Comparison with female volunteers. Am J Clin Nutr 1989; 48: 86–92.
Gwirtsman HE, Guze BH, Jager J, Gainsley B: Fluoxetine treatment of anorexia. An open trial. J Clin Psych 1990; 51: 378–382.
Halmi KA, Falk JR, Schwartz E: Binge-eating and vomiting: A survey of a college population. Psychol Med 1981; 11: 697–706.
Halmi KA, Eckert ED, LaDu TJ et al: Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986; 43: 177–181.
Hatsukami DK, Eckert ED, Mitchell JE, Pyle RL: Affective disorder and sub- stance abuse among women with bulimia. Psychol Med 1984; 14: 701–704.
Hendren RL: Depression in anorexia nervosa. J Am Acad Chld Psychiatry 1983; 22: 59–62.
Herzog DB: Bulimia in the adolescent. Am J Disord Children 1982; 136: 985–989. Herzog DB, Copeland PM: Eating disorders. N Eng J Med 1985; 313: 295–303.
Heufelder A, Warnhoff M, Pirke KM: Platelet alpha-2 andrenoceptor and adenyl-ate cyclase in patients with anorexia nervosa and bulimia. J Clin Endocrin Metab 1985; 61: 1053–1060.
Hsu LKG, Crisp AH, Harding B: Outcome of anorexia nervosa. Lancet 1970; is 61–65.
Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D: Phenomenologic relationship of eating disorders to major affective disorders. Psychiatry Res 1983a; 9: 345–354.
Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D: Family history study of anorexia nervosa and bulimia. Brit J Psychiatry 1983b; 142: 133–138.
Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D, Frankenburg FR: A controlled family history study of bulimia. Psychol Med 1987; 17: 883–890.
Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM: Treating bulimia with desipramine. Arch Gen Psychiatry 1986; 43: 182–186.
Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL: Obsessive-compulsive disorder and serotonin: Is there a connection? Biol Psychiatry 1985; 20: 1174–1188.
Jimerson DC, Lesern MD, Kaye WH, Brewerton TD: Symptom severity and neurotransmitter studies in bulimia. Psychopharmacology 1988; 96: S124.
Jimerson DC, Lesem MD, Hegg AP, Brewerton TD: Serotonin in human eating disorders, In: The Neuropharmacology of Serotonin, edited by PM WhitakerAzmitia and SJ Peroutka, Ann NY Acad Sci, 1990a; 600: 532–544.
Jimerson DC, Lesern MD, Kaye WH, Hegg AP, Brewerton TD: Eating disorders and depression: Is there a serotonin connection? Biol Psychiatry 1990b; 28: 443–454.
Johnson JL, Leiter LA, Burrow GN, Garfinkel PE, Anderson GH: Excretion of urinary catecholamine metabolites in anorexia nervosa: Effect of body composition and energy intake. Am J Clin Nutri 1984; 40: 1001–1006.
Jung RT, Shetty PS, Barrand M, Callingham BA, James WPT: Role of catecholamines in hypotensive response to dieting. Br Med J 1979; 1: 12.
Kahn RS, Van Praag MH, Wetzler RS: Serotonin and anxiety revisited. Biol Psychiatry 1988; 23: 189–208.
Kassett JA, Gerson ES, Maxwell ME, Guroff JJ, Kazuba DM, Smith AL, Brandt HA, Jimerson DC: Psychiatric disorders in the first-degree relatives of pro-bands with bulimia nervosa. Am J Psychiatry 1986; 11: 1468–1471.
Kasvikis YG, Tsakiris F, Marks IM, Basoglu M, Noshirvani HF: Past history of anorexia nervosa in women with obsessive compulsive disorder. Int J Eating Disorders 1986; 5: 1069–1075.
Kaye WH, Ebert MHY, Raleigh M, Lake CR: Abormalities in central nervous system monamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984a; 41: 350–355.
Kaye WH, Ebert MH, Gwirtsman HE, Weiss SR: Differences in brain serotonin metabolism between nonbulimic and bulimic patients with anorexia nervosa. Am J Psychiatry 1984b; 141: 1598–1601.
Kaye WH, Gwirtsman HE, Lake CR, Siever LJ, Jimerson DC, Ebert MH, Murphy DL: Disturbances of norepinephrine metabolism and alpha2 adrenergic receptor activity in anorexia nervosa: Relationship to nutritional state. Psychopharm Bull 1985a; 21: 419–423.
Kaye WH, Jimerson DC, Lake CR, Ebert MH: Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psych Res 1985b; 14: 333–342.
Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH: CSF 5-HIAA concentrations in anorexia nervosa: Reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 1988a; 23: 102–105.
Kaye WH, Gwirtsman H, Jimerson DC, George DT, Karoum F, Ebert MH, Lake CR: Catecholamine function in anorexia nervosa at low weight and after weight restoration. Prog Catecholamine Res, Part C: Clin Aspects 1988b; 355–361.
Kaye WH, Gwirtsman HE, Brewerton TD, George DT, Wurtman RJ: Bingeing behavior and plasma amino acids: A possible involvement of brain serotonin in bulimia nervosa. Psychiatry Research, 1988c; 23: 31–43.
Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR: Disturbances of noradrenergic systems in normal-weight bulimia:Relationship to diet and menses. Biol Psychiatry 1990a; 27: 4–21.
Kaye WH, Ballenger JC, Lydiard B, Stuart GW, Laraia MT, O’Neil P, Fossey M, Stevens V, Lesser S, Hsu LKG: CSF Monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. Am J Psychiatry 1990b; 147: 225–229.
Kaye WH, Gwirtsman HE, George DT, Ebert MH: Altered serotonin activity in anorexia nervosa after long-term weight restoration: Does elevated CSF 5-HIAA correlate with rigid and obsessive behavior? Arch Gen Psychiatry, 1991a; 48: 556–562.
Kaye WH, Weltzin TE, Hsu LKG, Bulik C: An open trial of fluoxetine in patients with anorexia nervosa. Journal of Clinical Psychiatry, 1991b; 52: 464–471.
Kennedy SH, Piran N, Garfinkel OE: Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. J Clin Psychopharmacol 1985; 5: 279–285.
Kennedy S, Piran N, Garfinkel PE: Isocarboxazede in the treatment of bulimia. Am J Psychiatry 1986; 143: 1495–1496.
Keys A: The Biology of Human Starvation, Minneapolis: University of Minnesota Press, 1950.
King A: Primary and secondary anorexia nervosa syndromes. Br J Psychiatry 1963; 109: 470–479.
Krahn D, Mitchell J: Use of L-tryptophan in treating bulimia (letter). Am J Psychiatry 1985; 142: 1130.
Lacey JH, Crisp AH: Hunger, food intake and weight: the impact of clomipram-ine on a refeeding anorexia nervosa population. Postgrad Med J 1980; 56: 79–85.
Laessle RG, Wittchen HU, Fichter MM, Pirke KM: The significance of subgroups of bulimia and anorexia nervosa: lifetime frequency of psychiatric disorders. Int J Eat Disord 1989; 8: 569–574.
Landsberg L, Young JB: Fasting, feeding and the regulation of sympathetic activity. N Engl J Med 1978; 298: 1295–1301.
Leibowitz SF: Noradrenergic function in the medial hypothalamus: Potential relation to anorexia nervosa and bulimia. In Pirke KM, Ploog D (Eds.), The Psychbiology of Anorexia Nervosa. Berlin: Springer-Verlag, 1984, p. 35.
Leibowitz SF, Shor-Posner G: Brain serotonin and eating behavior. Appetite 1986; 7: 1–14.
Leibowitz SF, Weiss GF, Yee F, Tretter JB: Noradrenergic innervation of the paraventricular nucleus: Specific role in control of carbohydrate ingestion. Brain Res Bull 1985; 14: 561–567.
Leon GR, Carroll K, Chernyk B, Finn S: Binge eating and associated habit patterns within college student and identified bulimic populations. In J Eating Disord 1985; 4: 43–57.
Lesom M, George DT, Kaye WH, Goldstein DS, Jimerson DC: State-related changes in norepinephrine regulation in anorexia nervosa. Biol Psychiatry 1989; 25: 509–512.
Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 1983; 33: 2609–2614.
Lonati-Galligani M, Pirke KM: Beta2-adrenergic receptor regulation in circulating mononuclear leukocytes in anorexia nervosa and bulimia. Psych Res 1986; 19: 189–198.
Luck P, Mikhailidis DP, Dashwood MR, Barradas MA, Sever PS, Dandona P, Wakeling A: Platelet hyperaggregability and increased alpha-adrenoceptor density in anorexia nervosa. J Clin Endocrin Metab 1983; 57: 911–914.
Mira M, Abraham S: L-tryptophan as an adjunct to treatment of bulimia nervosa (letter). Lanet 1989; ii: 1162–1163.
Mitchell JE, Groat R: A placebo-controlled double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984; 4: 186–193.
Mitchell JE, Hatsukami D, Eckert ED, Pyle RL: Characteristics of 275 patients with bulimia. Am J Psychiatry 1985; 142: 482–485.
Mitchell JE, Hatsukami D, Pyle R, Eckert E: Bulimia with and without a family history of drug abuse. Addictive Behav 1988; 13: 245–251.
Morgan H, Russell GFM: Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four-year follow-up study of 41 patients. Psychol Med 1975; 5: 355–371.
Myers RD, McCaleb ML: Feeding, satiety signal from intestine triggers brain’s noradrenergic mechanism. Science 1980; 209: 1035–1037.
Newman MM, Halmi KA, Marchi P: Relationship for clinical factors to calo-ric requirements in subtypes of eating disorders. Biol Psychiatry 1987; 22: 1253–1263.
Obarzanek E, Lesern M, Jimerson DC: Resting metabolic rate in bulimic patients (NR 204). Presented at the 140th Annual Meeting of the American Psychiatric Association, Chicago, 1990.
Pahl J, Pirke KM, Schweiger U, Warnhoff M, Gerlinghoff M, Brinkmann W, Berger M, Krieg C: Anorectic behavior, mood, and metabolic and endocrine adaptation to starvation in anorexia nervosa during inpatient treatment. Biol Psychiatry 1985; 20: 874–887.
Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R: Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry 1987; 144: 1543–1548.
Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA:Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077–1083.
Pfeiffer A, Herz A: Endocrine actions of opioids. Horm Metabol Res 1984; 16: 386–397.
Pirke KM, Spyra B: Catecholamine turnover in the brain and the regulation of luteinizing hormone and corticosterone in starved male rats. Acat Endocrinol 1982; 100: 168–176.
Pirke KM, Fichter MM, Pahl J: Noradrenaline, trijodthyronine, growth hormone and prolactin during weight gain in anorexia nervosa. Int J Eat Dis 1985a; 4: 499–509.
Pirke KM, Pahl J, Schweiger U, Warnhoff M: Metabolic and endocrine indices of starvation in bulimia: A comparison with anorexia nervosa. Psych Res 1985b; 15: 33–39.
Pirke KM, Ploog D: Psychobiology of anorexia nervosa. In: Wurtman RJ, Wurt-man JJ (Eds.), Nutrition and the Brain, New York: Raven Press, 1986, Vol. 7. Pirke KM, Eckert M, Ofers B, et al: Plasma norepinephrine response to exercise in bulimia, anorexia nervosa and controls. Biol Psychiat 1989; 25: 799–802.
Ploog D, Pirke KM: The Psychobiology of Anorexia Nervosa. Berlin: Springer-Verlag, 1984, 35–45.
Pope HG, Hudson JI: Antidepressant drug therapy for bulimia: Current status. J Clin Psychiatry 1986; 47: 339–345.
Pope HG, Hudson JI, Jonas JM, et al.: Bulimia treated with imipramine: A placebo controlled double-blind study. Am J Psychiatry 1983; 140: 554–558.
Pope HG, Hudson JI, Yurgelun-Todd D: Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry 1984; 141: 292–294.
Potter WZ, Muscettola G, Goodwin FK: Source of variance in clinical studies of MHPG. In: Maas JW (Ed.), MHPG: Base Mechanisms and Psychopathology, New York: Academic Press, 1983.
Pyle RL, Mitchell JE, Eckert ED: Bulimia: A report of 34 cases. J Clin Psychiatry 1981; 42: 60–64.
Riederer P, Toifl K, Kruzik P: Excretion of biogenic amine metabolites in anorexia nervosa. Clin Chem Acta 1982; 123: 27–32.
Rothenberg A: Differential diagnosis of anorexia nervosa and depressive illness: A review of 11 studies. Comp Psychiatry 1988; 29: 427–432.
Rowland C Jr: Anorexia nervosa. A survey of the literature and review of 30 cases. Int J Psych Clin 1970; 7: 37–137.
Russell GFM, Checkley SA, Feldman J, Eisler I: A controlled trial of d-fenfluram-ine in bulimia nervosa. Clin Neuropharmacol 1988; 11 (Supple 1): S146 - S159.
Silver JA: Anorexia nervosa: Clinical observations in a successful treatment plan. J Pediatr 1974; 84: 68.
Soubrie P: Reconciling the role of central serotonin neurosis in human and animal behavior. Behav Brain Sci 1986; 9: 319–363.
Stangler RS, Printz AM: DSB-III psychiatric diagnosis in a university population. Am J Psychiatr 1980; 137: 937–940.
Stonehill E, Crisp AH: Psychoneurotic characteristics of patients with anorexia nervosa before and after treatment and at follow-up 4–7 years later. J Psychosom Res 1977; 21: 187–193.
Strober M: Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J Psychosom Res 1980; 24: 353–359.
Strober M, Katz JL: Depression in the eating disorders: A review and analysis of descriptive, family, and biological findings. In: Garner DM, Garfinkel PE (Eds.), Diagnostic Issues in Anorexia Nervosa and Bulimia Nervosa: New York: Brunner/Mazel, 1988, 80–111.
Strober M, Lampert C, Morrell W, Burroughs J, Jacobs C: A controlled family study of anorexia nervosa: Evidence of familial aggregation and lack of shared transmission with affective disorders, Int J Eating Dis 1990; 9: 239–253.
Strober M, Salkin B, Burroughs J, Morrell W: Validity of the bulimia-restricter criteria in anorexia nervosa. J Nervous Mental Dis 1982; 170: 345–351.
Swift WJ, Andrews D, Barklage NE: The relationship between affective disorder and eating disorders: A review of the literature. Am J Psychiatry 1986; 143: 290–299.
Theander S: Anorexia nervosa: A psychiatric investigation of 94 female patients. Acta Psychiat Scand 1970; Suppl 214.
Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L: Clomipramine treatment of obsessive-compulsive disorder in a controlled clinical trial. Arch Gen Psychiatry 1985; 37: 1281–1285.
Van Loon GR: Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders. Metabolism 1980; (Suppl. 1) 29: 1198–1202.
Van Praag HM: CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet 1983; ii: 977–978.
Volavka J, Neziroglu F, Yaryura-Tobias JA: Clomipramine and imipramine in obsessive compulsive disorder. Psych Res 1985; 14: 85–93.
Walsh BT, Stewart JW, Roose SP, et al.: Treatment of bulimia with phenelzine: A double-blind, placebo controlled study. Arch Gen Psychiatry 1984; 41: 1105–1109.
Warren MP, Vandewiele RL: Clinical and metabolic features of anorexia nervosa. Am J Obstet Gynecol 1973; 117: 435.
Weisman R, Carmi M, Tyano S, Apter A, Rehavi M: High affinity [3H-imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci 1986; 38: 1235–1242.
Welle S, Lilavivathana U, Campbell RG: Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. Metabolism 1980; 29: 806–809.
Welle S, Lilavivathana U, Campbell RG: Thermic effects of feeding in man: Increased plasma norepinephrine levels following glucose, but not protein or fat consumption. Metab Exp 1981; 30: 953–958.
Wurtman JJ, Wurtman RJ: Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats. Life Science 1979; 24: 895–903.
Young JB, Rowe JW, Pallotta JA, Sparrow D, Landsbert L: Enhanced plasma norepinephrine response to uptight posture and oral glucose administration in elderly human subjects. Metab Clin Exp 1980; 29: 532–539.
Zemishlany Z, Modai A, Apter A, Jerushalmy Z, Samuel E, Tyano S: Serotonin (5-HT) uptake by blood platelets in anorexia nervosa. Acta Psychiatr Scand 1987; 75: 127–130.
Zohar J, Insel RH, Zohar-Kadouch RC, Hill JL, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Arch Gen Psychiatry 1988; 45: 167–172.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kaye, W.H., Weltzin, T.E., Hsu, L.K.G. (1993). Serotonin and Norepinephrine Activity in Anorexia and Bulimia Nervosa: Relationship to Nutrition, Feeding, and Mood. In: Mann, J.J., Kupfer, D.J. (eds) Biology of Depressive Disorders. The Depressive Illness Series, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9501-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9501-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9503-5
Online ISBN: 978-1-4757-9501-1
eBook Packages: Springer Book Archive